XIST/let-7i/HMGA1 axis maintains myofibroblasts activities in oral submucous fibrosis

Long non-coding RNA XIST promotes the development of various types of head and neck cancers, but its role in the progression of precancerous oral submucous fibrosis (OSF) has not been determined yet. As such, we aimed to examine whether XIST implicates in the regulation of myofibroblast activation. Our results showed that the expression of XIST was upregulated in OSF tissues and fibrotic buccal mucosal fibroblasts (fBMFs), and the silencing of XIST downregulated several myofibroblasts features. We demonstrated that elevation of let-7i after inhibition of XIST may lead to reduced myofibroblast activation. On the contrary, overexpression of high mobility group AT-Hook 1 (HMGA1) following the suppression of let-7i may result in enhanced myofibroblast activities. Moreover, we showed that the suppressive effect of silencing of XIST on myofibroblasts hallmarks was reversed by let-7i inhibition or HMGA1 overexpression, suggesting the pro-fibrotic property of XIST was mediated by downregulation of let-7i and upregulation of HMGA1. These findings revealed that myofibroblast activation of fBMFs may attribute to the alteration of the XIST/let-7i/HMGA1 axis. Therapeutic approaches to target this axis may serve as a promising direction to ameliorate the malignant progression of OSF.

Automated summary

Long non-coding RNA XIST promotes the development of various types of head and neck cancers. In this study, we investigated its role in the progression of precancerous oral submucous fibrosis (OSF) and found that XIST upregulation contributed to myofibroblast activation in OSF tissues and fibrotic buccal mucosal fibroblasts (fBMFs). We identified the XIST/let-7i/HMGA1 axis as a potential therapeutic target to ameliorate the malignant progression of OSF.